Annual Working Capital
$28.20 M
+$46.70 M+252.43%
31 December 2023
Summary:
Emergent BioSolutions annual working capital is currently $28.20 million, with the most recent change of +$46.70 million (+252.43%) on 31 December 2023. During the last 3 years, it has fallen by -$783.20 million (-96.52%). EBS annual working capital is now -96.85% below its all-time high of $895.90 million, reached on 31 December 2021.EBS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$431.50 M
+$396.70 M+1139.94%
30 September 2024
Summary:
Emergent BioSolutions quarterly working capital is currently $431.50 million, with the most recent change of +$396.70 million (+1139.94%) on 30 September 2024. Over the past year, it has increased by +$374.70 million (+659.68%). EBS quarterly working capital is now -51.84% below its all-time high of $895.90 million, reached on 31 December 2021.EBS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +252.4% | +659.7% |
| 3 y3 years | -96.5% | -42.2% |
| 5 y5 years | -93.3% | +1.6% |
EBS Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -96.8% | +252.4% | -51.8% | +2432.4% |
| 5 y | 5 years | -96.8% | +252.4% | -51.8% | +2432.4% |
| alltime | all time | -96.8% | +252.4% | -51.8% | +2432.4% |
Emergent BioSolutions Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $431.50 M(+1139.9%) |
| June 2024 | - | $34.80 M(-33.3%) |
| Mar 2024 | - | $52.20 M(+85.1%) |
| Dec 2023 | $28.20 M(-252.4%) | $28.20 M(-50.4%) |
| Sept 2023 | - | $56.80 M(-32.8%) |
| June 2023 | - | $84.50 M(+1408.9%) |
| Mar 2023 | - | $5.60 M(-130.3%) |
| Dec 2022 | -$18.50 M(-102.1%) | -$18.50 M(-102.2%) |
| Sept 2022 | - | $850.10 M(+5.3%) |
| June 2022 | - | $807.50 M(-5.1%) |
| Mar 2022 | - | $851.10 M(-5.0%) |
| Dec 2021 | $895.90 M(+10.4%) | $895.90 M(+20.1%) |
| Sept 2021 | - | $746.10 M(-4.9%) |
| June 2021 | - | $784.30 M(-3.3%) |
| Mar 2021 | - | $810.90 M(-0.1%) |
| Dec 2020 | $811.40 M(+72.7%) | $811.40 M(+23.0%) |
| Sept 2020 | - | $659.50 M(+31.3%) |
| June 2020 | - | $502.20 M(+19.7%) |
| Mar 2020 | - | $419.50 M(-10.7%) |
| Dec 2019 | $469.90 M(+11.8%) | $469.90 M(+10.6%) |
| Sept 2019 | - | $424.70 M(+8.5%) |
| June 2019 | - | $391.50 M(+39.8%) |
| Mar 2019 | - | $280.10 M(-33.4%) |
| Dec 2018 | $420.40 M(+9.1%) | $420.40 M(-8.8%) |
| Sept 2018 | - | $461.13 M(+3.7%) |
| June 2018 | - | $444.50 M(+14.0%) |
| Mar 2018 | - | $389.78 M(+1.2%) |
| Dec 2017 | $385.30 M(-4.7%) | $385.30 M(-19.8%) |
| Sept 2017 | - | $480.60 M(+10.0%) |
| June 2017 | - | $436.81 M(+3.6%) |
| Mar 2017 | - | $421.46 M(+4.2%) |
| Dec 2016 | $404.36 M(-7.6%) | $404.36 M(+9.4%) |
| Sept 2016 | - | $369.69 M(-12.8%) |
| June 2016 | - | $424.19 M(-3.1%) |
| Mar 2016 | - | $437.70 M(-0.0%) |
| Dec 2015 | $437.80 M | $437.80 M(+13.8%) |
| Sept 2015 | - | $384.76 M(+10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $348.53 M(+7.1%) |
| Mar 2015 | - | $325.51 M(-4.0%) |
| Dec 2014 | $339.24 M(+56.7%) | $339.24 M(+12.3%) |
| Sept 2014 | - | $302.21 M(+12.3%) |
| June 2014 | - | $269.02 M(+5.5%) |
| Mar 2014 | - | $254.88 M(+17.7%) |
| Dec 2013 | $216.46 M(+7.5%) | $216.46 M(+22.0%) |
| Sept 2013 | - | $177.38 M(-11.0%) |
| June 2013 | - | $199.38 M(+3.0%) |
| Mar 2013 | - | $193.54 M(-3.9%) |
| Dec 2012 | $201.44 M(+9.9%) | $201.44 M(-0.5%) |
| Sept 2012 | - | $202.36 M(+1.8%) |
| June 2012 | - | $198.75 M(+1.1%) |
| Mar 2012 | - | $196.55 M(+7.2%) |
| Dec 2011 | $183.36 M(+9.3%) | $183.36 M(+9.3%) |
| Sept 2011 | - | $167.83 M(+10.9%) |
| June 2011 | - | $151.34 M(+4.2%) |
| Mar 2011 | - | $145.27 M(-13.4%) |
| Dec 2010 | $167.77 M(+20.6%) | $167.77 M(+4.2%) |
| Sept 2010 | - | $160.98 M(+8.0%) |
| June 2010 | - | $149.00 M(+3.9%) |
| Mar 2010 | - | $143.41 M(+3.1%) |
| Dec 2009 | $139.11 M(+40.7%) | $139.11 M(+0.7%) |
| Sept 2009 | - | $138.11 M(+5.6%) |
| June 2009 | - | $130.81 M(+19.2%) |
| Mar 2009 | - | $109.72 M(+11.2%) |
| Dec 2008 | $98.87 M(+11.5%) | $98.66 M(-1.7%) |
| Sept 2008 | - | $100.41 M(+14.5%) |
| June 2008 | - | $87.66 M(-2.9%) |
| Mar 2008 | - | $90.25 M(+1.8%) |
| Dec 2007 | $88.65 M(+6.8%) | $88.65 M(+23.4%) |
| Sept 2007 | - | $71.85 M(+6.7%) |
| June 2007 | - | $67.35 M(-8.0%) |
| Mar 2007 | - | $73.22 M(-11.8%) |
| Dec 2006 | $82.99 M(+185.9%) | $82.99 M(+343.2%) |
| Sept 2006 | - | $18.73 M(-35.5%) |
| Dec 2005 | $29.02 M(+286.5%) | $29.02 M(+286.5%) |
| Dec 2004 | $7.51 M | $7.51 M |
FAQ
- What is Emergent BioSolutions annual working capital?
- What is the all time high annual working capital for Emergent BioSolutions?
- What is Emergent BioSolutions annual working capital year-on-year change?
- What is Emergent BioSolutions quarterly working capital?
- What is the all time high quarterly working capital for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly working capital year-on-year change?
What is Emergent BioSolutions annual working capital?
The current annual working capital of EBS is $28.20 M
What is the all time high annual working capital for Emergent BioSolutions?
Emergent BioSolutions all-time high annual working capital is $895.90 M
What is Emergent BioSolutions annual working capital year-on-year change?
Over the past year, EBS annual working capital has changed by +$46.70 M (+252.43%)
What is Emergent BioSolutions quarterly working capital?
The current quarterly working capital of EBS is $431.50 M
What is the all time high quarterly working capital for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly working capital is $895.90 M
What is Emergent BioSolutions quarterly working capital year-on-year change?
Over the past year, EBS quarterly working capital has changed by +$374.70 M (+659.68%)